BioSpace News Archive

Rani Therapeutics Holdings, Inc. reported financial results for the third quarter ended September 30, 2023, and provided a corporate update.

Tenaya Therapeutics, Inc. reported financial results and provided a corporate update for the third quarter ended September 30, 2023.

ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics, announced its third quarter 2023 financial results and provided a business update.

89bio, Inc. reported its financial results for the third quarter ended September 30, 2023.

Neurocrine Biosciences, Inc. will present at the Jefferies London Healthcare Conference on Tuesday November 14, 2023 at 3:00 p.m. Greenwich Mean Time in London.

Vanda Pharmaceuticals Inc. announced financial and operational results for the third quarter ended September 30, 2023.

Avidity Biosciences, Inc. reported financial results and recent highlights for the third quarter ended September 30, 2023.

Janssen Pharmaceuticals, Inc., a Johnson & Johnson company, today announced new data from the CorEvitas Psoriatic Arthritis (PsA) and Spondyloarthritis Registry that showed a substantial proportion of people living with treatment-resistant active PsA and using TREMFYA® (guselkumab) in real-world settings reported meaningful improvements in pain, physical function and fatigue through six months.

Corner Therapeutics announced the first publication detailing their proprietary Catalytic Adjuvant platform that drives strong T cell immune responses to mRNA vaccines.

Morphogenesis, Inc. announced positive biomarker analysis data from its first-in-human study evaluating IFx-Hu2.0 for patients with melanoma refractory to anti-PD1-based therapies.